| 8673924 |
Substituted pyrazolo[1,5-a]pyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan +15 more |
2014-03-18 |
$46,244,000 |
| 7807683 |
N-heteroaryl pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan +13 more |
2010-10-05 |
|
| 7790474 |
p53 modulators |
Bimalendu Dasmahapatra, Bernard R. Neustadt, Mark Demma, Henry A. Vaccaro, Jonathan A. Pachter |
2010-09-07 |
|
| 7700773 |
4-cyano, 4-amino, and 4-aminomethyl derivatives of pyrazolo[1,5-a]pyridines, pyrazolo[1,5-c]pyrimidines and 2H-indazole compounds and 5-cyano, 5-amino, and 5-aminomethyl derivatives of imidazo[1,2-a]pyridines, and imidazo[1,5-a]pyrazines as cyclin dependent kinase inhibitors |
Vincent S. Madison, Kamil Paruch |
2010-04-20 |
|
| 7635697 |
Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
— |
2009-12-22 |
|
| 7432268 |
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
Timothy J. Guzi, Kamil Paruch, Jocelyn Rivera, Ronald J. Doll, Viyyoor M. Girijavallabhan +3 more |
2008-10-07 |
$77,394,000 |
| 7432265 |
Imidazopyrazines as cyclin dependent kinase inhibitors |
Kamil Paruch, Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan |
2008-10-07 |
$77,394,000 |
| 7161003 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan +13 more |
2007-01-09 |
|
| 7138396 |
17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
Timothy J. Guzi, Kamil Paruch, Jocelyn Rivera, Ronald J. Doll, Viyyoor M. Girijavallabhan +3 more |
2006-11-21 |
$65,844,000 |
| 7119200 |
Pyrazolopyrimidines as cyclin dependent kinase inhibitors |
Timothy J. Guzi, Kamil Paruch, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan +13 more |
2006-10-10 |
|
| 6919341 |
Imidazopyrazines as cyclin dependent kinase inhibitors |
Kamil Paruch, Timothy J. Guzi, Michael P. Dwyer, Ronald J. Doll, Viyyoor M. Girijavallabhan |
2005-07-19 |
$160,529,000 |
| 6903102 |
17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
Timothy J. Guzi, Kamil Paruch, Jocelyn Rivera, Ronald J. Doll, Viyyoor M. Girijavallabhan +3 more |
2005-06-07 |
$55,356,000 |
| 6800636 |
Farnesyl protein transferase inhibitors |
Timothy J. Guzi, Dinanath F. Rane, Alan B. Cooper, Ronald J. Doll, Viyyoor M. Girijavallabhan +4 more |
2004-10-05 |
$72,060,000 |
| 6740661 |
Farnesyl protein transferase inhibitors |
Arthur G. Taveras, Ronald J. Doll, Alan B. Cooper, Johan Ferreira, Timothy J. Guzi +11 more |
2004-05-25 |
$144,697,000 |
| 6699872 |
N-substituted urea inhibitors of farnesyl-protein transferase |
Stacy Remiszewski |
2004-03-02 |
$88,219,000 |
| 6576639 |
Compounds for the inhibition of farnesyl protein transferase |
Ronald J. Doll, Joseph M. Kelly, F. George Njoroge, Stacy Remiszewski, Arthur G. Taveras |
2003-06-10 |
$120,833,000 |
| 6492381 |
Tricyclic carbamate compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
W. Robert Bishop, Ronald J. Doll, F. George Njoroge, Joanne M. Petrin, John J. Piwinski +3 more |
2002-12-10 |
$103,465,000 |
| 6365588 |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
Robert W. Bishop, Ronald J. Doll, F. George Njoroge, Joanne M. Petrin, John J. Piwinski +3 more |
2002-04-02 |
$153,994,000 |
| 6362188 |
Farnesyl protein transferase inhibitors |
Timothy J. Guzi, Dinanath F. Rane, Alan B. Cooper, Ronald J. Doll, Viyyoor M. Girijavallabhan +4 more |
2002-03-26 |
$111,648,000 |
| 6358968 |
N-substituted urea inhibitors of farnesyl-protein transferase |
Stacy Remiszewski |
2002-03-19 |
$170,668,000 |
| 6300338 |
Tricyclic carbamate compounds useful for inhibition of g-protein function and for treatment of proliferative diseases |
W. Robert Bishop, Ronald J. Doll, F. George Njoroge, Joanne M. Petrin, John J. Piwinski +3 more |
2001-10-09 |
$130,348,000 |
| 6242458 |
Tricyclic amide and urea compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
W. Robert Bishop, Ronald J. Doll, F. George Njoroge, Joanne M. Petrin, John J. Piwinski +3 more |
2001-06-05 |
$220,550,000 |
| 6214827 |
Tricyclic compounds useful for inhibition of G-protein function and for treatment of proliferative diseases |
Adriano Afonso, John J. Baldwin, Ronald J. Doll, Ge Li, F. George Njoroge +3 more |
2001-04-10 |
$295,894,000 |
| 6214828 |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative disease |
Ronald J. Doll, Joseph M. Kelly, F. George Njoroge, Stacy Remiszewski, Arthur G. Taveras |
2001-04-10 |
$295,894,000 |
| 6143758 |
Tricyclic amides useful for inhibition of G-protein function and for treatment of proliferative diseases |
Ronald J. Doll, Joseph M. Kelly, F. George Njoroge, Stacy Remiszewski, Arthur G. Taveras |
2000-11-07 |
$965,040,000 |
